First Trust NYSE Arca Biotechnology Index Fund Rating → This Weight Loss Company Can't Make Enough Product (From Behind the Markets) (Ad) Free FBT Stock Alerts $150.22 -0.05 (-0.03%) (As of 01:59 PM ET) Add Compare Share Share RatingsStock AnalysisChartHoldingsOwnershipRatingsStock AnalysisChartHoldingsOwnershipRatings First Trust NYSE Arca Biotechnology Index Fund Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FBT Aggregate RatingModerate Buy2.60Holdings in FBT have an aggregate rating of Moderate Buy based on 445 analyst ratings issued in the past year covering 30 companies (100.0% of the portfolio).FBT Aggregate Price Target$195.7030.27% UpsideHigh Prediction$265.82Average Prediction$195.70Low Prediction$142.84Holdings in FBT have an aggregate price target of $195.70 and a range of $142.84 to $265.82 covering 30 companies (100.0% of the portfolio).FBT Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy18 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by First Trust NYSE Arca Biotechnology Index Fund Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 30 FBT Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.67%MRNAModerna$133.84-2.9%4 of 5 stars2.24$129.02 -3.6%174.65%CORTCorcept Therapeutics$28.47-0.4%5 of 5 stars3.00$44.30 55.6%4Analyst Forecast4.23%HALOHalozyme Therapeutics$50.32+1.3%5 of 5 stars2.75$54.13 7.6%8Gap Up3.88%VRTXVertex Pharmaceuticals$470.90-0.6%4 of 5 stars2.52$443.55 -5.8%25Analyst Forecast3.77%UTHRUnited Therapeutics$305.77+2.9%4 of 5 stars2.90$312.22 2.1%10Insider Selling3.73%BNTXBioNTech$85.68-3.1%3 of 5 stars2.20$111.70 30.4%10Short Interest ↓3.71%BIIBBiogen$225.80-0.3%5 of 5 stars2.65$286.50 26.9%26Short Interest ↓3.67%NTRANatera$109.86-0.5%2 of 5 stars3.00$101.19 -7.9%16Positive News3.63%AMGNAmgen$305.32+0.7%5 of 5 stars2.52$305.85 0.2%21Short Interest ↓3.62%MTDMettler-Toledo International$1,478.41+2.1%4 of 5 stars2.00$1,256.25 -15.0%8Positive News3.54%BGNEBeiGene$154.04-3.4%2 of 5 stars2.80$251.93 63.5%10Short Interest ↓Positive News3.51%REGNRegeneron Pharmaceuticals$1,046.79+0.1%4 of 5 stars2.77$998.09 -4.7%22Analyst ForecastInsider Selling3.44%INCYIncyte$61.21-2.4%5 of 5 stars2.44$73.69 20.4%18Analyst Forecast3.30%ITCIIntra-Cellular Therapies$76.62+11.3%5 of 5 stars2.91$91.50 19.4%11Short Interest ↓Positive NewsGap UpHigh Trading Volume3.28%CPRXCatalyst Pharmaceuticals$14.90-0.7%5 of 5 stars3.00$26.71 79.3%5Short Interest ↓Positive News3.25%ARGXargenx$382.20+1.0%3 of 5 stars2.80$520.68 36.2%20Analyst ForecastAnalyst Revision3.19%ALNYAlnylam Pharmaceuticals$152.82-2.8%5 of 5 stars2.59$216.19 41.5%17Options VolumePositive News3.14%ALKSAlkermes$24.69-1.3%5 of 5 stars2.55$36.50 47.8%11Analyst ForecastShort Interest ↓News CoveragePositive News3.13%NBIXNeurocrine Biosciences$133.40-1.4%5 of 5 stars2.80$152.00 13.9%25Positive News3.10%GMABGenmab A/S$25.49-1.1%3 of 5 stars2.38$49.25 93.2%133.08%EXELExelixis$21.52-1.2%5 of 5 stars2.59$26.13 21.4%17Positive News2.98%GILDGilead Sciences$63.45-1.3%5 of 5 stars2.35$83.69 31.9%17Short Interest ↑2.95%WATWaters$293.65-0.2%4 of 5 stars1.91$307.20 4.6%11Positive News2.94%BEAMBeam Therapeutics$23.31-3.0%1 of 5 stars2.38$40.18 72.4%13Short Interest ↓2.86%ILMNIllumina$107.69-1.3%5 of 5 stars2.29$158.14 46.9%21Gap Up2.83%ACADACADIA Pharmaceuticals$14.71-0.9%4 of 5 stars2.75$28.94 96.7%162.78%BMRNBioMarin Pharmaceutical$85.63+0.7%5 of 5 stars2.57$106.11 23.9%21Short Interest ↓Positive News2.75%RGENRepligen$121.72-2.1%5 of 5 stars2.89$197.75 62.5%10Analyst ForecastPositive NewsGap Down2.35%BRKRBruker$65.55+1.1%5 of 5 stars2.56$85.00 29.7%9Positive News1.99%EXASExact Sciences$42.19+2.1%4 of 5 stars2.92$93.07 120.6%13 This page (NYSEARCA:FBT) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredBeta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and fi...Prosper Trading Academy | SponsoredThe ONE AI Stock to own now. (It’s not Nvidia.)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages...Weiss Ratings | SponsoredElon Musk: THIS will be bigger than TeslaIf you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you ...Paradigm Press | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredTrump’s arrest is phase oneIn this new documentary, you’ll discover the truth about Trump’s criminal conviction, who’s really pulling the...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust NYSE Arca Biotechnology Index Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust NYSE Arca Biotechnology Index Fund With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
